Cargando…
Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881403/ https://www.ncbi.nlm.nih.gov/pubmed/31776441 http://dx.doi.org/10.1038/s41598-019-54423-4 |
| _version_ | 1783473941461860352 |
|---|---|
| author | Diamanti, Klev Cavalli, Marco Pan, Gang Pereira, Maria J. Kumar, Chanchal Skrtic, Stanko Grabherr, Manfred Risérus, Ulf Eriksson, Jan W. Komorowski, Jan Wadelius, Claes |
| author_facet | Diamanti, Klev Cavalli, Marco Pan, Gang Pereira, Maria J. Kumar, Chanchal Skrtic, Stanko Grabherr, Manfred Risérus, Ulf Eriksson, Jan W. Komorowski, Jan Wadelius, Claes |
| author_sort | Diamanti, Klev |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6881403 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68814032019-12-06 Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes Diamanti, Klev Cavalli, Marco Pan, Gang Pereira, Maria J. Kumar, Chanchal Skrtic, Stanko Grabherr, Manfred Risérus, Ulf Eriksson, Jan W. Komorowski, Jan Wadelius, Claes Sci Rep Author Correction Nature Publishing Group UK 2019-11-28 /pmc/articles/PMC6881403/ /pubmed/31776441 http://dx.doi.org/10.1038/s41598-019-54423-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Diamanti, Klev Cavalli, Marco Pan, Gang Pereira, Maria J. Kumar, Chanchal Skrtic, Stanko Grabherr, Manfred Risérus, Ulf Eriksson, Jan W. Komorowski, Jan Wadelius, Claes Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes |
| title | Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes |
| title_full | Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes |
| title_fullStr | Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes |
| title_full_unstemmed | Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes |
| title_short | Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes |
| title_sort | author correction: intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881403/ https://www.ncbi.nlm.nih.gov/pubmed/31776441 http://dx.doi.org/10.1038/s41598-019-54423-4 |
| work_keys_str_mv | AT diamantiklev authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT cavallimarco authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT pangang authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT pereiramariaj authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT kumarchanchal authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT skrticstanko authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT grabherrmanfred authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT riserusulf authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT erikssonjanw authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT komorowskijan authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes AT wadeliusclaes authorcorrectionintraandinterindividualmetabolicprofilinghighlightscarnitineandlysophosphatidylcholinepathwaysaskeymoleculardefectsintype2diabetes |